Mayo Clinic - Q3 2020 holdings

$64.2 Million is the total value of Mayo Clinic's 9 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .

 Value Shares↓ Weighting
UBX  Unity Biotechnology Inc$5,439,000
-60.1%
1,571,9810.0%7.33%
-43.9%
CLPT  Clearpoint Neuro Inc (fka MRI INTERVENTIONS INC)$2,574,000
+1432.1%
47,1480.0%3.47%
+2054.7%
EVLO  Evelo Bioseciences Inc$2,556,000
+7.6%
484,9530.0%3.44%
+51.6%
CGIX  CANCER GENETICS INC$184,000
+18300.0%
4440.0%0.25%
+24700.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BLACK STONE MINERALS11Q3 202382.2%
Evelo Bioseciences Inc11Q3 20237.3%
BIOSIG TECH INC10Q2 20236.7%
Clearpoint Neuro Inc (Frmly MRI INTERVENTIONS INC)10Q3 20233.5%
Zentalis Pharmaceuticals Inc9Q3 202322.6%
UNITY BIOTECHNOLOGY INC8Q4 202223.1%
EXACT SCIENCES CORP7Q2 20234.5%
Neuroon Medical Technologies5Q3 20231.3%
MSCI ACWI ETF4Q3 202389.6%
Sorrento Therapeutics4Q4 20226.1%

View Mayo Clinic's complete holdings history.

Latest significant ownerships (13-D/G)
Mayo Clinic Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
VENTURE LENDING & LEASING IV INCMarch 16, 20056,0006.0%

View Mayo Clinic's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-09
13F-HR2023-05-05
13F-HR/A2023-02-09
13F-HR2023-01-26
13F-HR2021-08-12
13F-HR2021-05-13
13F-HR2021-02-11
13F-HR2020-11-12

View Mayo Clinic's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (64209000.0 != 74201000.0)

Export Mayo Clinic's holdings